| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.066 | 0.05 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | -0.38 | 0.05 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.05 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.05 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.36 | 0.05 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.05 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.063 | 0.06 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.11 | 0.06 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.06 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.068 | 0.06 |